Achievements of BCGVL

  • New cGMP facility for manufacturing was taken over in March 2016.
  • After undertaking trial and consistency batches, obtained Manufacturing and sale License in form 28D (Commercial License) from SLA for cGMP facility in October 2019.
  • Production of commercial batches was initiated in December 2019.
  • From July 2020, BCGVL started supplying BCG vaccine manufactured in cGMP compliant facility to Universal Immunization Programme (UIP).
  • For Financial Year 2020-21, BCGVL supplied 170 lakh doses to Universal Immunization Programme (UIP).
  • BCGVL supplied 270 lakh doses for FY 2021-2022.
  • Established PCR based molecular biology technique for Genotypic Identification of BCG vaccine.
  • Developed Green Belt in the BCG campus.